TNNI3 and aortic stenosis: Troponins also seem to be promising biomarkers for use in managing patients with AS as they are associated with long-term risk of AVR and mortality, especially high-sensitivity cardiac troponin T [64] and high-sensitivity cardiac troponin I (cTnI) [65].